Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Briumvi 150 mg concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
Ublituximab
Company:  
Neuraxpharm UK Ltd See contact details
ATC code: 
L04AG14
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL)
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 07 Nov 2025

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Neuraxpharm UK Ltd
Company image
Address
Neuraxpharm UK Ltd, Suite 2, Arlington Flex, Third Floor, Building 1420, Arlington Business Park, Theale, Reading, Berkshire, RG7 4SA, UK
Telephone
0118 211 4039
E-mail
[email protected]
Adverse event reporting email
[email protected]
Medical Information e-mail
[email protected]